Cardio-oncology: An ongoing evolution

Bradley J. Petek, Chris Greenman, Joerg Herrmann, Michael S. Ewer, Robin L. Jones

Research output: Contribution to journalReview article

8 Scopus citations

Abstract

Cancer survivorship has been greatly impacted with the development of modern cancer treatments. While significant strides have been made in managing many types of cancer, now physicians face new challenges. Over the past decades, cardiovascular events in cancer survivors have increased in prevalence, driving the development of multidisciplinary cardio-oncology programs. Additionally, as cancer patients live longer, their risk of developing secondary cardiovascular events increases. The rapid development of novel cancer therapies will continue to generate questions of cardiac risk and cardiac protection in cancer patients over time. We wish to outline the development of cardio-oncology in its present state, and provide future perspectives for the discipline.

Original languageEnglish (US)
Pages (from-to)2059-2066
Number of pages8
JournalFuture Oncology
Volume11
Issue number14
DOIs
StatePublished - Jan 1 2015

Keywords

  • anthracycline
  • cancer therapy
  • cardio-oncology
  • cardiotoxicity

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cardio-oncology: An ongoing evolution'. Together they form a unique fingerprint.

  • Cite this

    Petek, B. J., Greenman, C., Herrmann, J., Ewer, M. S., & Jones, R. L. (2015). Cardio-oncology: An ongoing evolution. Future Oncology, 11(14), 2059-2066. https://doi.org/10.2217/fon.15.89